The International Prognostic Scoring System does not accurately discriminate different risk categories in patients with post-essential thrombocythemia and post-polycythemia vera myelofibrosis

Ítems similars

• Value of cytogenetic abnormalities in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a study of the MYSEC project
  per: Mora, Barbara, et al.
  Publicat: (2018)
• Significance of thrombocytopenia in patients with primary and post-essential thrombocythemia/polycythemia vera myelofibrosis
  per: Masarova, Lucia, et al.
  Publicat: (2018)
• Application of current prognostic models for primary myelofibrosis in the setting of post-polycythemia vera or post-essential thrombocythemia myelofibrosis
  per: Tefferi, A, et al.
  Publicat: (2017)
• Patients with post-essential thrombocythemia and post-polycythemia vera differ from patients with primary myelofibrosis
  per: Masarova, Lucia, et al.
  Publicat: (2017)
• Allogeneic Hematopoietic Stem Cell Transplantation for Post-essential Thrombocythemia and Post-polycythemia Vera Myelofibrosis
  per: Murata, Makoto, et al.
  Publicat: (2020)